A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.…
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of…
UK’s GSK announces $30 billion U.S. pharma investment amid Trump state visit
Rafael Henrique | Lightrocket | Getty Images Britain’s GSK on Wednesday became the latest pharmaceutical firm to commit…
What’s likely to move the market in the next trading session
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…
Eli Lilly’s Daniel Skovronsky talks obesity pill data
The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images…
Jim Cramer’s top 10 things to watch in the stock market Tuesday
My top 10 things to watch Tuesday, Aug. 26 1. Federal Reserve Board Governor Lisa Cook said she…
Meta shares fall on AI restructuring report, while Lilly shrugs off Novo’s Ozempic price move
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Eli Lilly hikes price of Mounjaro in UK amid Trump pressure
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy…
Novo Nordisk offers diabetes drug Ozempic for steep cash discount
A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie…
10 things to watch in the stock market Monday including Nvidia and geopolitics
The Club’s 10 things to watch Monday, Aug. 18 — Today’s newsletter was written by Zev Fima, the…
Eli Lilly and health-care stocks are week’s big winners, 3 sectors fell
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
‘Don’t quit the market’ when it’s frothy, says Jim Cramer. Here’s why
CNBC’s Jim Cramer on Thursday said that although the market may be frothy, investors shouldn’t quit because there…